drugset / Trial / NCT00942539

Midazolam Sedation for Neonatal Lumbar Puncture

NCT00942539

Phase 2 Terminated 12 enrolled Rambam Health Care Campus
RandomizedParallel-groupSingle-blindTreatment

Summary

Lumbar puncture is one of the most common painful procedures performed on neonates in the Emergency Department (ED). The investigators will study in a randomized controlled trial, the efficacy of intravenous administration of a single dose of Midazolam in reducing pain and anxiety in neonates undergoing lumbar puncture in the ED, as well as the rate of adverse sedation reactions. The investigators hypothesize that compared with placebo, single dose Midazolam would significantly decrease pain and anxiety and will have low rate of adverse reactions.

Timeline

Start
2009-07
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 0.05 mg/kg Intravenous

Indications